Last reviewed · How we verify

Parentral Iron — Competitive Intelligence Brief

Parentral Iron (Parentral Iron) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement therapy. Area: Hematology.

marketed Iron replacement therapy Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Parentral Iron (Parentral Iron) — Services Institute of Medical Sciences, Pakistan. Parenteral iron replenishes depleted iron stores by delivering iron directly into the bloodstream or muscle tissue, bypassing gastrointestinal absorption limitations.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Parentral Iron TARGET Parentral Iron Services Institute of Medical Sciences, Pakistan marketed Iron replacement therapy
IV iron - Sodium Ferric Gluconate Complex IV iron - Sodium Ferric Gluconate Complex Rambam Health Care Campus marketed Iron replacement therapy Iron (Fe3+) delivery to erythropoietic tissues
Supplementation of iron sucrose Supplementation of iron sucrose Medical University of Vienna marketed Iron replacement therapy
Low Molecular Weight Iron Dextran Low Molecular Weight Iron Dextran University of Washington marketed Iron replacement therapy
Iron-Dextran Complex Injection [InFed] Iron-Dextran Complex Injection [InFed] Oregon Health and Science University marketed Iron replacement therapy
IV iron infusion IV iron infusion NICHD Global Network for Women's and Children's Health marketed Iron replacement therapy
ferumoxytol or oral iron ferumoxytol or oral iron AMAG Pharmaceuticals, Inc. phase 3 Iron replacement therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement therapy class)

  1. AMAG Pharmaceuticals, Inc. · 1 drug in this class
  2. Medical University of Vienna · 1 drug in this class
  3. NICHD Global Network for Women's and Children's Health · 1 drug in this class
  4. Nicoletta C Machin · 1 drug in this class
  5. Oregon Health and Science University · 1 drug in this class
  6. Pharmacosmos A/S · 1 drug in this class
  7. Rambam Health Care Campus · 1 drug in this class
  8. Services Institute of Medical Sciences, Pakistan · 1 drug in this class
  9. Sumitomo Pharma America, Inc. · 1 drug in this class
  10. University of Washington · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Parentral Iron — Competitive Intelligence Brief. https://druglandscape.com/ci/parentral-iron. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: